| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.17 | 6e-05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.54 | 0.0003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.44 | 0.0006 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |